• GSK343 and EZH2 Inhibition: Epigenetic Leverage for Translat

  2026-05-15

  This article explores the mechanistic underpinnings and translational opportunities of GSK343, a potent and selective EZH2 inhibitor, in the context of cancer immunogenicity and epigenetic reprogramming. Integrating recent discoveries around PRC2, H3K27 methylation, and CBX2-mediated immune evasion, we provide strategic guidance for researchers seeking to harness GSK343’s unique attributes in precision epigenetic oncology. We contrast GSK343’s performance with other tool compounds, address workflow optimization, and map out the future of epigenetic modulation for immunotherapy.

• BRD4770: Reliable G9a Inhibition for Robust Epigenetic Assay

  2026-05-15

  Laboratory reproducibility in epigenetic and cell proliferation assays hinges on both molecular specificity and product integrity. BRD4770 (SKU B4837) enables precise inhibition of G9a histone methyltransferase, supporting bench scientists with validated workflows and data-backed reliability. This scenario-driven guide details best practices and critical decision points for leveraging BRD4770 in advanced cancer biology research.

• NAD+/NADH Balance in Fungal Hypoxia: Metabolic Adaptation Me

  2026-05-14

  This review dissects how NAD+/NADH homeostasis underpins metabolic adaptation to hypoxia and secondary metabolite production in filamentous fungi. By detailing redox-triggered pathway shifts and regulatory mechanisms, the study illuminates fundamental processes relevant to bioindustrial fermentation, disease modeling, and mitochondrial research.

• Harnessing Cefoperazone Sodium Salt in Antimicrobial Assays

  2026-05-14

  Cefoperazone sodium salt stands out in antimicrobial research for its robust β-lactamase stability and proven broad-spectrum efficacy. This article delivers actionable workflows, troubleshooting guidance, and comparative insights—empowering researchers to optimize in vitro antibacterial activity assays and resistance studies with confidence.

• HyperFluor™ 594 Goat Anti-Rabbit IgG: Specificity & Protocol

  2026-05-13

  The HyperFluor™ 594 Goat Anti-Rabbit IgG (H+L) Antibody is an affinity-purified, fluorophore-conjugated secondary antibody from APExBIO. It enables sensitive, multiplexed detection of rabbit IgG in immunocytochemistry, IHC, and flow cytometry, with strict protocol parameters for optimal signal and specificity. This dossier details its mechanism, benchmarks, and practical integration in advanced research workflows.

• EPZ5676: Transforming DOT1L Inhibitor Workflows in Leukemia

  2026-05-13

  EPZ5676, a highly selective DOT1L inhibitor, empowers researchers to dissect H3K79 methylation with unmatched precision. This guide delivers practical workflow strategies, troubleshooting insights, and comparative advantages for MLL-rearranged leukemia studies.

• DiscoveryProbe™ Metabolism-related Compound Library: Technic

  2026-05-12

  The DiscoveryProbe™ Metabolism-related Compound Library provides researchers with a rigorously validated, ready-to-use collection of 493 metabolism-related small molecules, streamlining high-throughput metabolic enzyme assays and pathway studies. It is designed for in vitro and ex vivo research only and should not be used for diagnostic or clinical applications.

• IBDV VP3 Protein Suppresses IRF7 to Enhance Viral Replicatio

  2026-05-12

  This study reveals that infectious bursal disease virus (IBDV) exploits its VP3 protein to degrade interferon regulatory factor 7 (IRF7) and suppress type I interferon responses in chicken cells. These findings uncover a novel viral evasion mechanism, with implications for controlling immunosuppressive diseases in poultry.

• Bazedoxifene: Applied SERM Workflows for Osteoporosis Resear

  2026-05-11

  Bazedoxifene empowers researchers to dissect estrogen receptor signaling and bone mineral density enhancement with unmatched tissue selectivity. Explore optimized experimental protocols, comparative advantages, and troubleshooting tips for robust postmenopausal osteoporosis models.

• Nerve-Controlled HDAC1 Expression Drives Axolotl Limb Regene

  2026-05-11

  This study reveals that nerve-mediated upregulation of histone deacetylase 1 (HDAC1) is essential for blastema formation and successful limb regeneration in axolotls. Pharmacological inhibition of HDACs, including with TSA, disrupts this process, highlighting critical epigenetic regulation linking nerve signaling and regenerative capacity.

• G418 Sulfate: Precision Selection Meets Antiviral Innovation

  2026-05-10

  Explore how Geneticin (G-418 Sulfate) transcends its legacy as a genetic engineering selection antibiotic, offering not only robust neomycin resistance screening but also promising antiviral activity—particularly against Dengue virus serotype 2. This article integrates mechanistic insights, state-of-the-art protocol guidance, and translational strategies, positioning APExBIO’s Geneticin as a pivotal tool for next-generation biomedical research.

• M344: Potent Histone Deacetylase Inhibitor for Cancer Resear

  2026-05-09

  M344 is a cell-permeable histone deacetylase inhibitor used to modulate gene expression and induce cell differentiation in cancer and HIV-1 latency models. It displays nanomolar IC50 potency and robustly inhibits breast cancer, medulloblastoma, and neuroblastoma cell proliferation. Evidence supports its role as an advanced tool for epigenetic research and workflow integration.

• E. coli Uracil-DNA Glycosylase (UDG): Technical Lab Guidance

  2026-05-08

  E. coli Uracil-DNA Glycosylase (UDG) is designed for the precise removal of uracil residues from DNA, supporting PCR contamination control and DNA repair workflows. It is not suitable for RNA, oligonucleotides shorter than six bases, or any diagnostic or clinical use. Researchers should apply it strictly within scientific research protocols where uracil excision from DNA is required.

• Primidone (Mysoline): Protocols and Innovations for TRPM3 &

  2026-05-08

  Primidone (Mysoline) offers unique selectivity as both a TRPM3 and RIPK1 inhibitor, enabling translational research in neurodevelopmental and neurodegenerative models. Explore optimized workflows, troubleshooting strategies, and data-driven dosing for reliable in vitro and in vivo outcomes.

• GSK126 EZH2 Inhibitor: Transforming Cancer Epigenetics Workf

  2026-05-07

  GSK126, a highly selective EZH2 inhibitor, empowers researchers to dissect PRC2-dependent gene silencing in cancer and stem cell models with unmatched precision. Its proven ability to enable self-renewal in naive pluripotent stem cells and enhance sensitivity to chemotherapeutics makes it indispensable for cutting-edge oncology and epigenetics research.

15737 records 1/1050 page Next 12345 下5页 Last page